Artwork

Inhalt bereitgestellt von MDedge and Medscape Professional Network. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von MDedge and Medscape Professional Network oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Player FM - Podcast-App
Gehen Sie mit der App Player FM offline!

Biologics for pediatric psoriasis and atopic dermatitis

20:25
 
Teilen
 

Manage episode 282817040 series 2356616
Inhalt bereitgestellt von MDedge and Medscape Professional Network. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von MDedge and Medscape Professional Network oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

In the news:

Pityriasis rosea carries few risks for pregnant women

Adjuvant nivolumab plus ipilimumab shows strong results in resected stage IV melanoma

* * *

Because psoriasis and atopic dermatitis (AD) can greatly affect quality of life in pediatric patients, the development of treatments with low-side effect profiles and less laboratory monitoring is essential. Vincent A. DeLeo, MD, talks to Amy S. Paller, MD, and Jennifer B. Scott, MD, about biologics approved for psoriasis and AD in the pediatric population. “Progressively, we’ve seen the newer biologics being more and more effective in both adults and in children, so we’re able to take some of the more effective ones and apply them to our children and adolescents with psoriasis ... We keep raising the bar in children as well as adults,” Dr. Paller reflects. They also discuss the advantages and pitfalls of biologics versus traditional systemic treatments as well as therapies on the horizon.

Article: https://www.mdedge.com/dermatology/article/231217/atopic-dermatitis/biologics-pediatric-psoriasis-and-atopic-dermatitis

Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT106005224.PDF

* * *

Hosts: Nick Andrews, Vincent A. DeLeo, MD (University of Southern California, Los Angeles)

Guests: Amy S. Paller, MD (department of dermatology and the department of pediatrics, Northwestern University, Chicago) and Jennifer B. Scott, MD (department of dermatology, Northwestern University)

Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Paller has been an investigator and/or consultant for numerous companies. Dr. Scott reports no conflict of interest.

Show notes by: Allegra Sparta, Melissa Sears

* * *

You can find more of our podcasts at http://www.mdedge.com/podcasts

Email the show: podcasts@mdedge.com

Interact with us on Twitter: @MDedgeDerm

  continue reading

106 Episoden

Artwork
iconTeilen
 
Manage episode 282817040 series 2356616
Inhalt bereitgestellt von MDedge and Medscape Professional Network. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von MDedge and Medscape Professional Network oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

In the news:

Pityriasis rosea carries few risks for pregnant women

Adjuvant nivolumab plus ipilimumab shows strong results in resected stage IV melanoma

* * *

Because psoriasis and atopic dermatitis (AD) can greatly affect quality of life in pediatric patients, the development of treatments with low-side effect profiles and less laboratory monitoring is essential. Vincent A. DeLeo, MD, talks to Amy S. Paller, MD, and Jennifer B. Scott, MD, about biologics approved for psoriasis and AD in the pediatric population. “Progressively, we’ve seen the newer biologics being more and more effective in both adults and in children, so we’re able to take some of the more effective ones and apply them to our children and adolescents with psoriasis ... We keep raising the bar in children as well as adults,” Dr. Paller reflects. They also discuss the advantages and pitfalls of biologics versus traditional systemic treatments as well as therapies on the horizon.

Article: https://www.mdedge.com/dermatology/article/231217/atopic-dermatitis/biologics-pediatric-psoriasis-and-atopic-dermatitis

Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT106005224.PDF

* * *

Hosts: Nick Andrews, Vincent A. DeLeo, MD (University of Southern California, Los Angeles)

Guests: Amy S. Paller, MD (department of dermatology and the department of pediatrics, Northwestern University, Chicago) and Jennifer B. Scott, MD (department of dermatology, Northwestern University)

Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Paller has been an investigator and/or consultant for numerous companies. Dr. Scott reports no conflict of interest.

Show notes by: Allegra Sparta, Melissa Sears

* * *

You can find more of our podcasts at http://www.mdedge.com/podcasts

Email the show: podcasts@mdedge.com

Interact with us on Twitter: @MDedgeDerm

  continue reading

106 Episoden

Все серии

×
 
Loading …

Willkommen auf Player FM!

Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.

 

Kurzanleitung